Clinical Trials on Limited Systemic Sclerosis
Total 187960 results
-
Duke UniversityCompletedLimited Dorsiflexion | Limited Ankle Range of MotionUnited States
-
University College, LondonVersus ArthritisActive, not recruitingSystemic Sclerosis | Limited Cutaneous Systemic SclerosisUnited Kingdom
-
Cumberland PharmaceuticalsRecruitingPathologic Processes | Skin Diseases | Autoimmune Diseases | Connective Tissue Diseases | Scleroderma, Systemic | Scleroderma, Diffuse | Scleroderma, Limited | Sclerosis, Progressive SystemicUnited States, India
-
Schulthess KlinikCompletedLimited Hip MobilitySwitzerland
-
Tufts UniversityCompletedSedentary | Functionally LimitedUnited States
-
Seattle Children's HospitalEnrolling by invitationLimited English ProficiencyUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of MedicineRecruiting
-
Seattle Children's HospitalCompletedDisparities | Limited English Proficiency
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
University of California, San FranciscoMount Zion Health FundCompletedPerioperative Care | Limited English ProficiencyUnited States
-
Clalit Health ServicesTel Aviv UniversityCompletedLimited Participation in Daily Life ActivitiesIsrael
-
Gilead SciencesCompletedDiffuse Scleroderma | Limited SclerodermaAustralia
-
Ivoclar Vivadent AGActive, not recruitingCaries Pit and Fissure Limited to EnamelGermany, Switzerland
-
Imam Abdulrahman Bin Faisal UniversityCompletedStaff Anaesthesiologists | Limited Experience in Using VideolaryngoscopesSaudi Arabia
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
UMC UtrechtBoehringer Ingelheim; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingSystemic Sclerosis | Scleroderma, Diffuse | Mycophenolate Mofetil | Scleroderma | Autologous Stem Cell Transplantation | Cyclophosphamide | Systemic Scleroses, Diffuse | Treatment StrategyItaly, Switzerland, Netherlands, Sweden, United Kingdom
-
Barnes Retina InstituteCompletedNuclear Sclerotic CataractUnited States
-
Cairo UniversityUnknownLimited Information on Dental Radiography in Egypt
-
ChemomAb Ltd.CompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC) | Systemic Sclerosis (SSc)Israel
-
Mayo ClinicEnrolling by invitationArtificial Intelligence | Machine Learning | Limited English Proficiency | Language Barrier | Complex Medical NeedsUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Harvard Medical School (HMS and HSDM)Boston Children's Hospital; Ashwini Health System, Gudalur, India; Harvard Center... and other collaboratorsCompletedSpinal Anesthesia | Task Sharing in Anesthetic Delivery in Areas With Limited Access to CareUnited States, India
-
Bagcilar Training and Research HospitalCompleted
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
Seattle Children's HospitalCompletedLimited English Proficient Patients and FamiliesUnited States
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
-
Weill Medical College of Cornell UniversityRecruitingUnresectable Liver-limited Colorectal MetastasesUnited States
-
University Hospital, Strasbourg, FranceRecruitingVascular Disease | Raynaud Disease | Healthy Control Subjects | Undifferentiated Connective Tissue Disease | Scleroderma (Limited and Diffuse)France
-
University of Texas Southwestern Medical CenterCompletedSymmetric Limited MorpheaUnited States
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
Assiut UniversityUnknown
-
W. Leroy GriffingRecruitingSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Hennepin Healthcare Research InstituteCompletedAll Eligible ED Patients (Not Limited to a Particular Condition)United States
-
Horizon Therapeutics Ireland DACRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicNetherlands, Spain, Germany, United States, Japan, France, Italy, Korea, Republic of, Portugal, Israel, Greece, Argentina, Austria, Mexico, Poland, Switzerland, United Kingdom, Romania, Chile
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis | Relapsing Forms of Multiple Sclerosis